Best The Science Commons Initiative Podcasts (2025)

1
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)

Play Pause

1M ago

—

This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we highly recommend listening to part 3 of our follicular lymphoma series. You may also recall that we discussed these agents in our DLBCL series. Be sure …

1
Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)

1M ago

—

This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an upcoming episode. If you have not done so, we highly recommend listening to part 1 and part 2 of this follicular lymphoma series so that you can better …

1
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management

4M ago

—

This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. Episode contents: - What is the front-line approach to management for localized follicular lymphoma? - What about diffuse disease in a patient wh…

1
Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction

5M ago

—

This week, we kick off a new series, this time focusing on follicular lymphoma! This series will build on a lot of fundamentals that we discussed in our prior series. In this first episode, we start with an introduction to how to approach management of this disease. Episode contents: - What is the best approach to biopsy? - What is the differential…

1
Episode 135: VTE Series - Management of Antiphospholipid Antibody Syndrome

6M ago

—

This week, we round out our discussion we started in our prior episode on APLS, this time focusing on management. Stick around until the end to hear Dan and Vivek battle it out about the optimal time to recommend APLS testing for your patients! If you have not done so already, we highly recommend you check out episode 134 (diagnosis of APLS) prior …

1
Episode 134: VTE Series - Diagnosis of Antiphospholipid Antibody Syndrome

6M ago

—

This week, we continue our series focusing on venous thromboembolism. In this episode, we begin our discussion of antiphospholipid syndrome. Episode contents: - What is "antiphospholipid antibody syndrome"? - How do we make this diagnosis? - What is the optimal time to test for these antibodies? **** Get paid to participate in market research surve…

1
Episode 133: VTE Series - Perioperative Anticoagulation Management and Emergent Reversal

6M ago

—

This week, we discuss another set of high yield topic for anyone who cares for patients on anticoagulation - how to safely hold anticoagulation prior to a procedure and how to reverse the effects of the drug in the even of an emergent situation. We discuss our approach to how we discuss this with our patients and our medical colleagues! Dan also sh…

1
Episode 132: VTE Series- Approach to Hypercoagulable/Thrombophilia Testing

7M ago

—

This week, we talk all about hypercoagulable testing - a very common referral in outpatient hematology. Who do we consider testing on? Who should we encourage not to test? We discuss this and more here. Episode contents: - What are situations in which to consider hypercoaguable testing? - What are situations to avoid doing so? **** Get paid to part…

1
Episode 131: VTE Series-Approach to workup and initial management

7M ago

—

This week, we kick off a new, highly-anticipated and highly-requested series, covering venous thromboembolism (VTE). In this first episode, we discuss how we make the initial diagnosis and how we approach initial management. As a clinician, you will undoubtedly come across the need to make this decision. This episode and this series will set you up…

1
Episode 130: Testicular Cancer Series, Pt 4 - Role of Radiation Oncology

8M ago

—

This week, we welcome Dr. Amar Kishan to our show to discuss the role of radiation oncology in the management of patients with testicular cancer. As our listeners know by now, the management of patients with testicular cancer spans multiple specialities. We always appreciate hearing from our colleagues about their perspective. Episode contents: - W…

1
Episode 129: Testicular Cancer Series, Pt 3 - Disseminated and relapsed/refractory disease

8M ago

—

This week, we talk all about disseminated testicular cancer, highlighting our current treatment modalities and why we do what we do. We also cover refractory disease. This episode builds on our prior discussions in Parts 1 and 2, so be sure to check these out if you haven’t already! Episode contents: - A history lesson about how we developed our cu…

1
Episode 128: Testicular Cancer Series, Pt 2 - Stage 1 and 2

9M ago

—

This week, we continue on our testicular cancer journey, focusing on Stage 1 and 2 disease. If you haven’t done so, we highly recommend checking out Episode 127 for our overview of this disease! Episode contents: - What it the approach to stage 1 seminoma and non-seminoa? Radiation? Chemotherapy? Surgery? - What about stage 2 disease? - What are th…

1
Episode 127: Testicular Cancer Series, Pt 1 - Introduction

9M ago

—

It’s time for another new series, this time focusing on Testicular Cancer. In this first episode, we lay the foundation for our future discussions and discuss the basics of Testicular Cancer. Episode contents: - What are germ cell tumors? - What are important tumor markers to monitor for germ cell tumors? - Seminoma vs. Non-seminoma - Staging of ge…

1
Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease

10M ago

—

This week, we round out our AML series with a detailed discussion about the approach to management of relapsed and refractory disease. This has been a VERY long road going through all management of AML. We hope that you have continued to build on our discussions week-to-week. An exciting treatment paradigm that is ever-evolving! Episode contents: -…

1
Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy

10M ago

—

In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy. Episode contents: - How do we assess fitness for intensive AML? - What are options for patients who are unfit for intensive chemotherapy for AML? - What are important genetic mutations are important to check for? - What are the key trials …

1
Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML

10M ago

—

In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transplant for the treatment of AML. Episode contents: - What are the different conditioning regimens available? - How do we decide which re…

1
Episode 123: AML Series, Pt 9 - Introduction to Allogeneic Transplant

11M ago

—

In today’s episode, we welcome back Dr. Amar Kelkar for part 1 of our two-part discussion on allogeneic transplant. In this episode, we discuss the fundamental approach to patient selection and stem cell source selection. As you all know from this series, allogeneic transplants play a pivotal role in the management of AML. Dr. Kelkar’s pearls of wi…

1
Episode 122: AML Series, Pt 8 - AML Maintenance Therapies

11M ago

—

This week, we continue our series focusing on acute myeloid leukemia. In this episode, we talk about maintenance therapies in AML. Episode contents: - A recap of cytarabine consolidation - Why do we do maintenance therapy? - What are hypomethylating agents and how do they work? - Important targeted agents that play a role in maintenance therapy ***…

1
Episode 121: AML Series, Pt 7 - AML Consolidation: Role of Allogeneic Transplant

12M ago

—

This week, we continue our discussion on consolidation and maintenance therapies for AML, this time highlighting the role of allogeneic stem cell transplants. This episode builds on our prior episode, so if you have not listened to this just yet, we highly recommend doing so! Episode contents: - A recap on approach to AML consolidation - The role o…

1
Episode 120: AML Series, Pt 6 - AML Consolidation: Therapeutic Approaches

12M ago

—

This week, we move to our next phases of therapy for AML, which are consolidation and maintenance. Be sure to check out our prior episodes for a discussion on initial workup and how we incorporate recurrent genetic abnormalities into how we think about AML. Check out figure 1 from this paper for a helpful diagram! Episode contents: - A recap on app…

1
Episode 119: AML Series, Pt 5 - AML Induction: Options for Upfront Therapy

1y ago

—

This week, we round out our discussion regarding AML induction, this time focusing on the treatment options in the first line setting. We go through the various options, the dosing strategies, and the data behind them. Be sure to check out parts one and two of this three-part induction discussion, as we continue to build on these concepts! Also, if…

1
Episode 118: AML Series, Pt. 4 - AML Induction: Approach to Initial Management

1y ago

—

In this week’s episode, we continue onto part two of our three-part discussion on AML induction, this week focusing on selecting our up-front regimen. Be sure to check out last week’s episode, as this one builds on that one. Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this c…

1
Episode 117: AML Series, Pt. 3 - AML Induction: Definitions and Overview

1y ago

—

In this week’s episode, we start our three-part discussion on AML induction, this week focusing on key definitions and an overview of treatment. Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this conversation! Episode contents: - What are "blasts"? - If there is concern for AM…

1
Robbie Mochrie on How to Think like an Economist 38:24

1y ago38:24

38:24

The questions of what economics is and the role of an economist have long been at the heart of the profession, igniting extensive debate about the nature, scope, potential, and limitations of the discipline. Today, we’ll take a historical approach to these issues, exploring how past thinkers—ranging from Aristotle and Aquinas to Adam Smith and the …

1
Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification

1y ago

—

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this conversation! Episode contents:…

1
Episode 115: AML Series, Pt. 1 - CHIP, CCUS, ICUS, oh my!

1y ago

—

This week, we kick off a new series focusing on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this first episode, we discuss the alphabet soup of premalignant hematologic conditions including CHIP, CCUS, and ICUS, before moving onto MDS and AML in future episodes. Episode contents: - What is CHIP vs. CCUS vs. ICUS? - What is t…

1
Episode 114: Acute Promyelocytic Leukemia (REBOOT!)

1y ago

—

By popular demand, our next series that we are excited to share with you is on MDS/AML! As we prepare for the release of the first episode next week, let’s throw it back to Episode 019 in our Heme/Onc Emergencies Series and talk about APL! Episode contents: - How do we diagnose APL? - What are characteristic findings of APL? - What is the acute man…

1
Episode 113: Sickle Cell Series - “Double Duty: A Doctor's Story of Living with Sickle Cell Disease While Caring for Others”

1y ago

—

This week, we have an INCREDIBLE episode for you. We welcome Titilope Fasipe, MD, PhD, who not only is the Co-Director of the Sickle Cell and Thalassemia Program at Texas Children’s and an Assistant Professor in the Department of Pediatrics at the Baylor College of Medicine, she herself also has sickle cell disease! Dr. Fasipe takes us through her …

1
Exploring Space Medicine with Dr. Shauna Pandya 34:18

1y ago34:18

34:18

Show SummaryIn this episode, Chris talks with Dr. Shauna Pandya, a physician, aquanaut, skydiver, and pilot in training. She shares her diverse background and interests to include her degrees in neuroscience and space studies, as well as her role as the director of the International Institute for Astronautical Sciences Space Medicine Group. She als…

1
Episode 112: Sickle Cell Series - Chronic Management of Sickle Cell Disease

1y ago

—

In this week’s episode, we discuss the management of sickle cell disease in the chronic setting. This is a follow up to episode 111 where we discussed acute management of SCD. And furthermore, this is also in addition to our prior discussion about long-term chronic complications from SCD in episode 110. We highly recommend checking out these prior …

1
Episode 111: Sickle Cell Series - Acute Management of Sickle Cell Disease

1y ago

—

In this week’s episode, we discuss the management of acute complications of sickle cell disease including acute pain episodes and acute chest syndrome as well as a discussion of hyperhemolytic syndrome. Contents: - How to manage patients with sickle cell disease presenting for acute pain crises - How to approach management of acute chest syndrome -…

1
Episode 110: Sickle Cell Series - Chronic Complications in Sickle Cell Disease

1y ago

—

In this week’s episode, we discuss chronic complications that can arise in patients with sickle cell disease. The reality is, that unless we have an outpatient clinic or rotate through an outpatient clinic, there is a small chance that we will come across many of these issues. However, screening for and managing these chronic complications can have…

1
Episode 109: Sickle Cell Series - Introduction to Sickle Cell Disease

1y ago

—

It’s time for another new series, this time focusing on Sickle Cell Disease! In this first episode, we lay the foundation for our future discussions. This episode can be dense, but rest assured we will revisit these concepts and expand on them throughout the series. Contents: - What is hemoglobin? - What is the underlying problem in sickle cell dis…

1
Oliver Volckart on how Germany created its first common currency in the 16th century 34:40

1y ago34:40

34:40

The concept of a monetary union today implies a multilateral entity that centralizes the emission of a common currency shared by multiple countries. This arrangement provides benefits, such as lower transaction costs, but poses challenges, especially without a complete fiscal union, which can create perverse incentives. However, monetary issues are…

1
Episode 108: Colorectal Cancer Series, Pt. 10 - Metastatic Colorectal Cancer (Part 2)

1+ y ago

—

This week, we round out our discussion on metastatic colorectal cancer, focusing on more targeted therapies for this disease. If you have not done so already, be sure to check out episode 107 for the first part of our metastatic colorectal cancer discussion. Contents: - What is the role of immunotherapy? - What is the role of BRAF inhibition? - Can…

1
Episode 107: Colorectal Cancer Series, Pt. 9 - Metastatic Colorectal Cancer (Part 1)

1+ y ago

—

This week, we continue our discussion of colorectal cancer, turning our attention to metastatic disease, specifically for cancers without targetable mutations. If you have not done already, we highly recommend you check out episode 104 for our GI oncology pharmacology discussion! Contents: - What information do we need when we approach a new patien…

1
New Fellow Bootcamp Series: When Anticoagulation Fails (part 2)

1+ y ago

—

** Be sure to check out our rotation guide for more show notes and episodes organized by disease type: https://www.thefellowoncall.com/rotation-guides ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast s…

1
New Fellow Bootcamp Series: When Anticoagulation Fails (pt. 1)

1+ y ago

—

An exciting new academic year is about to begin. We know this can be daunting, especially for our newest hematology/oncology fellows. Over the next two weeks, we re-boot some of our high yield episodes you need to know to prepare for your first days as a new fellow and your nights on call. Next up: When anticoagulation fails, Part 1! [Originally ep…

1
New Fellow Bootcamp Series: HIT/HITT

1+ y ago

—

An exciting new academic year is about to begin. We know this can be daunting, especially for our newest hematology/oncology fellows. Over the next two weeks, we re-boot some of our high yield episodes you need to know to prepare for your first days as a new fellow and your nights on call. Next up: Heparin-induced thrombocytopenia! [Originally epis…

1
New Fellow Bootcamp Series: Cord compression

1+ y ago

—

An exciting new academic year is about to begin. We know this can be daunting, especially for our newest hematology/oncology fellows. Over the next two weeks, we re-boot some of our high yield episodes you need to know to prepare for your first days as a new fellow and your nights on call. Next up: Cord compression! [Originally episode 014] Content…

1
New Fellow Bootcamp Series: SVC Syndrome

1+ y ago

—

An exciting new academic year is about to begin. We know this can be daunting, especially for our newest hematology/oncology fellows. Over the next two weeks, we re-boot some of our high yield episodes you need to know to prepare for your first days as a new fellow and your nights on call. Next up: Superior vena cava (SVC) syndrome ! [Originally ep…

1
New Fellow Bootcamp Series: Metastatic Cancer of “Origin TBD”

1+ y ago

—

An exciting new academic year is about to begin. We know this can be daunting, especially for our newest hematology/oncology fellows. Over the next two weeks, we re-boot some of our high yield episodes you need to know to prepare for your first days as a new fellow and your nights on call. Next up: Metastatic Cancer of “Origin TBD,” a common questi…

1
New Fellow Bootcamp Series: ITP

1+ y ago

—

An exciting new academic year is about to begin. We know this can be daunting, especially for our newest hematology/oncology fellows. Over the next two weeks, we re-boot some of our high yield episodes you need to know to prepare for your first days as a new fellow and your nights on call. Next up: immune thrombocytopenic purpura [Originally episod…

1
GRC as a token? #4 -- Airdrop logistics and mechanics 50:04

1+ y ago50:04

50:04

Airdrop logistics and mechanicsBy Gridcoin Network

1
New Fellow Bootcamp Series: TTP

1+ y ago

—

An exciting new academic year is about to begin. We know this can be daunting, especially for our newest hematology/oncology fellows. Over the next two weeks, we re-boot some of our high yield episodes you need to know to prepare for your first days as a new fellow and your nights on call. First up: thrombotic thrombocytopenic purpura (TTP) [Origin…

1
Episode 106: Colorectal Cancer Series, Pt. 8 - Early Onset Colorectal Cancer

1+ y ago

—

In a recent American Cancer Society publication, there are increasing data that rates of colorectal cancer are rising rapidly among people in their 20s, 30s and 40s. This has certainly caught the attention of the lay press, most recently in a widely circulated New York Times article published in March 2024. Today, we welcome Dr. Chris Cann, who is …

1
GRC as a token? #3 -- New, Parallel, or Interconnected Systems? 24:04

1+ y ago24:04

24:04

Fireside 3By Gridcoin Network

1
Francisco Bethencourt on the History of the New Christian Trading Elite in the Early Modern Period 59:24

1+ y ago59:24

59:24

In 1492, Spain's Alhambra Decree forced Jews to convert to Christianity or face expulsion, leading many to become conversos. Portugal issued a similar edict in 1496. Driven by a desire for religious homogeneity, these measures led to persistent discrimination based on Jewish ancestry. How did this new group of New Christians defend their interests …